Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	300.91	315.35	386.19	200.84	86.47	183.88
Cash & Short-Term Investments	300.91	315.35	386.19	200.84	86.47	183.88
Cash Growth	-9.21%	-18.34%	92.29%	132.26%	-52.97%	-16.41%
Receivables	161.4	142	94.82	37.7	-	-
Inventory	16.32	15.73	15.14	4.32	-	-
Prepaid Expenses	16.01	11.98	8.12	2.78	0.05	0.15
Total Current Assets	494.63	485.06	504.26	245.64	86.52	184.02
Property, Plant & Equipment	24.07	5.97	7.62	1.14	0.94	1.79
Goodwill	12.04	12.04	12.04	10.31	-	-
Other Intangible Assets	45.32	46.89	53.29	59.66	-	-
Other Long-Term Assets	20.61	18.53	11.03	14.72	0.32	0.32
Total Assets	596.67	568.5	588.24	331.48	87.79	186.13
Accounts Payable	85.66	72	40.68	38.61	13.15	13.5
Accrued Expenses	146.42	145.61	90.5	51.63	9.3	8.71
Current Portion of Leases	2.27	3.26	1.27	0.43	0.62	1.22
Current Income Taxes Payable	0.96	0.96	-	-	-	-
Other Current Liabilities	8.6	8.29	6.41	5.9	-	-
Total Current Liabilities	243.91	230.1	138.85	96.56	23.07	23.44
Long-Term Debt	181.38	180.71	178.07	94.26	49.09	48.32
Long-Term Leases	27.59	8.99	7.04	-	-	0.58
Other Long-Term Liabilities	90.59	91.68	73.3	31.1	-	-
Total Liabilities	543.47	511.48	397.26	221.92	72.15	72.34
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	1,235	1,180	1,027	705.89	424.83	392.59
Retained Earnings	-1,182	-1,123	-835.57	-596.33	-409.2	-278.8
Shareholders' Equity	53.21	57.02	190.98	109.56	15.63	113.79
Total Liabilities & Equity	596.67	568.5	588.24	331.48	87.79	186.13
Total Debt	211.23	192.96	186.37	94.68	49.71	50.12
Net Cash (Debt)	89.68	122.4	199.82	106.16	36.76	133.75
Net Cash Growth	-36.85%	-38.75%	88.23%	188.77%	-72.51%	-33.13%
Net Cash Per Share	1.86	2.55	4.40	2.61	0.98	3.59
Filing Date Shares Outstanding	49.24	48.77	47.37	43.52	38.48	37.41
Total Common Shares Outstanding	49.22	48.67	47.35	43.5	37.82	37.37
Working Capital	250.72	254.96	365.41	149.08	63.45	160.59
Book Value Per Share	1.08	1.17	4.03	2.52	0.41	3.04
Tangible Book Value	-4.16	-1.92	125.65	39.59	15.63	113.79
Tangible Book Value Per Share	-0.08	-0.04	2.65	0.91	0.41	3.04

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q